• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

局部应用阿可乐定对白内障囊外摘除联合小梁切除术后眼压升高频率的影响。

Effect of topical apraclonidine on the frequency of intraocular pressure elevations after combined extracapsular cataract extraction and trabeculectomy.

作者信息

Robin A L

机构信息

School of Hygiene and Public Health, Johns Hopkins University, Baltimore, MD.

出版信息

Ophthalmology. 1993 May;100(5):628-33. doi: 10.1016/s0161-6420(93)31603-9.

DOI:10.1016/s0161-6420(93)31603-9
PMID:8098520
Abstract

PURPOSE

A trabeculectomy is frequently combined with extracapsular cataract surgery to minimize the risks of further optic nerve damage associated with intraocular pressure (IOP) elevations after cataract surgery in eyes with glaucoma. Acute IOP elevations still occur after this combined surgery. The author evaluated the efficacy of 1% topical apraclonidine, a relatively selective alpha 2 agonist, in minimizing this complication.

METHODS

A prospective, randomized, double-masked study compared topical 1% apraclonidine with placebo. All eyes underwent otherwise uncomplicated combined trabeculectomy and extracapsular cataract surgery. They received the appropriate study drug before, immediately after, and 12 hours after surgery. Intraocular pressures were measured 24 hours and 1, 2, and 4 weeks after surgery.

RESULTS

One hundred nine eyes (of 109 patients) underwent combined surgery. Fifty-nine received placebo. Preoperative mean IOPs were 22.5 +/- 4.2 mmHg for eyes treated with placebo and 24.0 +/- 7.7 mmHg for eyes treated with apraclonidine. Twenty-four hours after surgery, mean IOPs were 23.1 +/- 17.4 mmHg for placebo-treated eyes and 11.6 +/- 11.3 mmHg for apraclonidine-treated eyes (P < 0.001). Twenty-four hours after surgery, 12 (20%) placebo-treated eyes and 1 (2%) apraclonidine-treated eye had IOPs greater than 40 mmHg (P < 0.005).

CONCLUSION

Apraclonidine effectively decreased large IOP elevations in glaucomatous eyes undergoing trabeculectomy combined with extracapsular cataract surgery.

摘要

目的

小梁切除术常与白内障囊外摘除术联合进行，以降低青光眼患者白内障手术后因眼压升高导致视神经进一步损伤的风险。但这种联合手术后仍会出现急性眼压升高的情况。作者评估了1%局部用阿可乐定（一种相对选择性的α2激动剂）在减少该并发症方面的疗效。

方法

一项前瞻性、随机、双盲研究将局部用1%阿可乐定与安慰剂进行了比较。所有眼睛均接受了无其他并发症的小梁切除术联合白内障囊外摘除术。患者在手术前、手术后立即以及手术后12小时接受相应的研究药物。在手术后24小时以及1、2和4周测量眼压。

结果

109例患者的109只眼睛接受了联合手术。59只眼睛接受了安慰剂治疗。接受安慰剂治疗的眼睛术前平均眼压为22.5±4.2 mmHg，接受阿可乐定治疗的眼睛术前平均眼压为24.0±7.7 mmHg。手术后24小时，接受安慰剂治疗的眼睛平均眼压为23.1±17.4 mmHg，接受阿可乐定治疗的眼睛平均眼压为11.6±11.3 mmHg（P<0.001）。手术后24小时，12只（20%）接受安慰剂治疗的眼睛和1只（2%）接受阿可乐定治疗的眼睛眼压高于40 mmHg（P<0.005）。

结论

阿可乐定可有效降低接受小梁切除术联合白内障囊外摘除术的青光眼患者的眼压大幅升高。

相似文献

1
Effect of topical apraclonidine on the frequency of intraocular pressure elevations after combined extracapsular cataract extraction and trabeculectomy.局部应用阿可乐定对白内障囊外摘除联合小梁切除术后眼压升高频率的影响。
Ophthalmology. 1993 May;100(5):628-33. doi: 10.1016/s0161-6420(93)31603-9.
2
Apraclonidine and anterior segment laser surgery. Comparison of 0.5% versus 1.0% apraclonidine for prevention of postoperative intraocular pressure rise.阿可乐定与眼前节激光手术。0.5%与1.0%阿可乐定预防术后眼压升高的比较。
Ophthalmology. 1995 Sep;102(9):1312-8. doi: 10.1016/s0161-6420(95)30869-x.
3
Brimonidine 0.2% versus apraclonidine 0.5% for prevention of intraocular pressure elevations after anterior segment laser surgery.0.2%溴莫尼定与0.5%阿可乐定预防眼前节激光术后眼压升高的比较
Ophthalmology. 2001 Jun;108(6):1033-8. doi: 10.1016/s0161-6420(01)00545-0.
4
Brimonidine 0.15% versus apraclonidine 0.5% for prevention of intraocular pressure elevation after anterior segment laser surgery.0.15%溴莫尼定与0.5%阿可乐定预防眼前节激光术后眼压升高的比较
J Cataract Refract Surg. 2005 Sep;31(9):1707-12. doi: 10.1016/j.jcrs.2005.02.035.
5
The effect of 1% apraclonidine on intraocular pressure after cataract surgery.1%阿可乐定对白内障手术后眼压的影响。
Ophthalmic Surg Lasers. 1998 Jun;29(6):472-5.
6
Effects of 0.5% and 0.25% apraclonidine on postoperative intraocular hypertension after cataract extraction.0.5%和0.25%阿可乐定对白内障摘除术后高眼压的影响。
Eur J Ophthalmol. 1998 Apr-Jun;8(2):67-70. doi: 10.1177/112067219800800203.
7
The effect of 0.25% apraclonidine in preventing intraocular pressure elevation after Nd:YAG laser posterior capsulotomy.0.25%阿可乐定预防钕:钇铝石榴石激光后囊切开术后眼压升高的效果
Eur J Ophthalmol. 1998 Jul-Sep;8(3):167-72. doi: 10.1177/112067219800800309.
8
Effectiveness of apraclonidine and acetazolamide in preventing postoperative intraocular pressure spikes after extracapsular cataract extraction.
J Cataract Refract Surg. 1995 Mar;21(2):191-5. doi: 10.1016/s0886-3350(13)80509-3.
9
Apraclonidine 0.5% versus 1% for controlling intraocular pressure elevation after argon laser trabeculoplasty.0.5%与1%阿可乐定用于控制氩激光小梁成形术后眼压升高的比较
Ophthalmic Surg Lasers. 1996 Aug;27(8):657-60.
10
Preventing intraocular pressure increase after phacoemulsification and the role of perioperative apraclonidine.
J Cataract Refract Surg. 2002 Dec;28(12):2177-80. doi: 10.1016/s0886-3350(02)01454-2.

引用本文的文献

1
Neuroprotection for treatment of glaucoma in adults.用于治疗成人青光眼的神经保护。
Cochrane Database Syst Rev. 2017 Jan 25;1(1):CD006539. doi: 10.1002/14651858.CD006539.pub4.
2
Neuroprotection for treatment of glaucoma in adults.用于治疗成人青光眼的神经保护作用。
Cochrane Database Syst Rev. 2013 Feb 28;2(2):CD006539. doi: 10.1002/14651858.CD006539.pub3.
3
Effects of common topical antiglaucoma medications on the ocular surface, eyelids and periorbital tissue.常见局部抗青光眼药物对眼表面、眼睑和眼眶组织的影响。
Drugs Aging. 2011 Apr 1;28(4):267-82. doi: 10.2165/11588830-000000000-00000.
4
Neuroprotection for treatment of glaucoma in adults.用于治疗成人青光眼的神经保护。
Cochrane Database Syst Rev. 2010 Feb 17(2):CD006539. doi: 10.1002/14651858.CD006539.pub2.
5
Pharmacological therapy for glaucoma: a review.青光眼的药物治疗：综述
Drugs. 2000 Mar;59(3):411-34. doi: 10.2165/00003495-200059030-00003.
6
First day follow up for routine phacoemulsification?白内障超声乳化术常规随访的第一天？
Br J Ophthalmol. 1996 Feb;80(2):148-50. doi: 10.1136/bjo.80.2.148.
7
Topical apraclonidine hydrochloride in eyes with poorly controlled glaucoma. The Apraclonidine Maximum Tolerated Medical Therapy Study Group.局部应用盐酸阿可乐定治疗控制不佳的青光眼。阿可乐定最大耐受药物治疗研究组。
Trans Am Ophthalmol Soc. 1995;93:421-38; discussion 439-41.